自動調剤機の世界市場-2024～2031年

自動調剤機の世界市場は2023年に50億6,000万米ドルに達し、2031年には86億2,000万米ドルに達すると予測され、予測期間2024～2031年のCAGRは6.9%で成長する見込みです。

自動調剤機（ADM）は、薬剤を制御された方法で調剤するように設計された高度なコンピュータ化装置であり、手作業による調剤プロセスに関連するエラーのリスクを大幅に最小化します。テクノロジーを薬剤管理に取り入れることで、ヘルスケア施設は業務効率を向上させると同時に、患者の安全性と満足度を確保することができます。

自動調剤機により患者ケアユニットで安全な薬剤保管を実現します。ADMは、人為的ミスを最小限に抑え、ラベルの貼り間違いや誤った投薬量のリスクを低減することで、調剤の正確性を高めます。ADMには、バーコードスキャンやコンピュータ追跡などの先進技術が搭載されており、正しい患者に正しい薬剤を確実に提供することができます。

市場力学：

促進要因と阻害要因

医療過誤の増加

医療ミスの発生率の増加が自動調剤機市場を牽引すると予想されます。投薬ミスは患者の安全性に重大なリスクをもたらすため、ヘルスケアプロバイダーは調剤精度を向上させるソリューションを追求しています。

医療ミスを減らすため、ヘルスケアプロバイダーはいくつかの自動調剤ソリューションを採用しており、これが市場を牽引すると期待されています。2023年の国立衛生研究所の発表によると、ADCと従来の病棟在庫を比較したスイスの研究によると、ADCは調剤ミスを5%から1%に大幅に削減できることが分かったと言及されています。台湾で行われた別の研究では、ADCがスタットオーダーのみの処方箋の調剤に使用されたにもかかわらず、ADCの採用後に調剤ミスが75％減少したことがわかりました。

テクノロジーの革新、特に自動調剤機（ADM）は、こうしたエラーを最小限に抑える能力を高めています。高度な分析や機械学習機能などの機能がADMに統合され、安全で正確な投薬の確保におけるADMの有効性がさらに高まっています。

医療ミスを減らす自動調剤システムの技術的進歩が進んでいます。各社は、顧客に効率的なソリューションを提供するため、そのソリューションを進化させています。例えば、2024年4月、Omnicellは、顧客のヘルスケア施設に既存のXT自動調剤システムを強化することで、現在の薬局ケア提供モデルを最適化することを目的とした複数年にわたるイノベーションプロジェクト、XT Amplifyを開始しました。

2023年10月、JVMとHanmi Scienceは、ロボットアームを搭載した次世代型自動調剤機を独自に開発し、欧州市場で販売を開始しました。さらにJVMは、オランダでBrocacef社と供給契約を締結したと発表しました。

高額な初期投資

自動調剤機の導入が直面している主な課題の一つは、購入と導入に多額の初期投資が必要なことです。このようなシステムには、ハードウェアの購入だけでなく、ソフトウェアの統合や設置費用など、多額の初期費用がかかるのが一般的です。小規模なヘルスケア施設や薬局、特に厳しい予算制約の下で運営されている施設では、このような投資に必要な資金を割り当てるのに苦労するかもしれません。このような経済的負担は、高度な薬剤管理ソリューションを導入する妨げとなる可能性があります。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

• 影響要因
  • 促進要因
    • 医療ミスの発生率増加
  • 抑制要因
    • 初期投資額が高い
  • 機会
  • 影響分析

第5章 産業分析

• ポーターのファイブフォース分析
• サプライチェーン分析
• 価格分析
• 特許分析
• 規制分析
• SWOT分析
• アンメットニーズ

第6章 タイプ別

• 集中型
• 分散型

第7章 サイズ別

• フルサイズ自動調剤機
• カウンタートップ自動調剤機

第8章 エンドユーザー別

• 専門薬局
• 小売薬局
• 病院
• 研究所

第9章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • スペイン
  • イタリア
  • その他欧州地域
• 南米
  • ブラジル
  • アルゼンチン
  • その他南米
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• 中東・アフリカ

第10章 競合情勢

• 競合シナリオ
• 市況・シェア分析
• M&A分析

第11章 企業プロファイル

• Omnicell
  • 会社概要
  • 製品ポートフォリオと概要
  • 財務概要
  • 主な発展
• Nordson Corporation
• Baxter
• bdtronic
• Capsa Healthcare
• TouchPoint Medical
• McKesson Medical-Surgical Inc.
• Swisslog Healthcare
• ARxIUM
• ScriptPro LLC

第12章 付録

The global automated dispensing machines market reached US$ 5.06 billion in 2023 and is expected to reach US$ 8.62 billion by 2031, growing at a CAGR of 6.9% during the forecast period 2024-2031.

Automated dispensing machines (ADMs) are advanced computerized devices designed to dispense medications in a controlled manner, greatly minimizing the risk of errors associated with manual dispensing processes. By incorporating technology into medication management, healthcare facilities can improve operational efficiency while simultaneously ensuring patient safety and satisfaction.

Automated dispensing machines provide secure medication storage in patient care units. ADMs enhance the accuracy of medication dispensing by minimizing human error and reducing the risk of mislabeling or incorrect dosages. They are equipped with advanced technologies such as barcode scanning and computerized tracking to ensure that the correct medications are provided to the right patients.

Market Dynamics: Drivers & Restraints

Increasing incidence of medical errors

The increasing incidence of medical errors is expected to drive the automated dispensing machines market. Medication errors present significant risks to patient safety, prompting healthcare providers to pursue solutions that improve the accuracy of medication dispensing.

To reduce medical errors healthcare providers are adopting several automated dispensing solutions that are expected to drive the market. According to the publication in the National Institute of Health in 2023, it is mentioned that according to a Swiss study comparing ADCs with traditional ward stocks found that ADCs can significantly reduce dispensing errors from 5 to 1%. Another study conducted in Taiwan found that dispensing errors were reduced by 75% after the adoption of ADCs, even though ADCs were used to dispense prescriptions with only stat orders.

Innovations in technology, particularly within automated dispensing machines (ADMs), are enhancing their ability to minimize these errors. Features such as advanced analytics and machine learning capabilities are being integrated into ADMs, further increasing their effectiveness in ensuring safe and precise medication administration.

There is a growing technological advancements in automated dispensing systems that reduce medical errors. Companies are advancing their solutions to provide their customers with efficient solutions. For instance, in April 2024, Omnicell launched its XT Amplify, a multi-year innovation project that aims to optimize the current pharmacy care delivery model by enhancing the existing XT Automated Dispensing Systems in their client's healthcare facilities.

In October 2023, JVM, Hanmi Science independently developed and launched a next-generation automated drug dispensing machine equipped with a robotic arm in the European market. JVM further announced that it had entered a supply contract in the Netherlands with Brocacef.

High Initial Investment

One of the primary challenges facing the adoption of automated dispensing machines is the substantial initial investment required for their purchase and implementation. These systems typically entail significant upfront costs, which include not only the acquisition of hardware but also software integration and installation expenses. Smaller healthcare facilities and pharmacies, particularly those operating under tight budget constraints, may struggle to allocate the necessary capital for such an investment. This financial burden can hinder their ability to adopt advanced medication management solutions.

Segment Analysis

The global automated dispensing machines market is segmented based on type, size end-user, and region.

Product Type:

Decentralized segment is expected to dominate the global automated dispensing machines market share

The decentralized segment is expected to hold the dominant position in the global automated dispensing machines market. This is due to their ability to enhance medication management and improve patient safety. These systems allow medications to be stored closer to the point of care, significantly reducing the time healthcare professionals need to access necessary medications. This rapid availability is particularly crucial in emergencies, where timely medication administration can directly impact patient outcomes.

For instance, studies have shown that hospitals using decentralized automated dispensing cabinets have experienced a reduction in medication administration errors by up to 75%, underscoring the effectiveness of these systems in enhancing patient safety and overall care quality.

Geographical Analysis

North America is expected to hold a significant position in the global automated dispensing machines market share

North America holds a dominant position in the global automated dispensing machines market and is expected to hold the major portion of the market during the forecast period. North America's anticipated dominance in the automated dispensing machines market is driven by high adoption rates of automation, technological innovations, and favorable market growth projections. As healthcare providers continue to recognize the benefits of ADMs in enhancing operational efficiency and improving patient outcomes, the region is poised for sustained growth in this sector.

Increasing technological advancements are expected to drive the region's automated dispensing machines. Market players are innovating advanced solutions that meet the needs and demands of pharmacies and hospitals. For instance, in March 2024, Nordson EFD introduced the new GVPlus and PROX families of automated fluid dispensing products. Both robotic solutions share a focus on motion, workspace, repeatability, payload, setup, and vision technology enhancements.

Additionally, the presence of numerous key players in the region further supports market growth, fostering innovation and competition within the automated dispensing machines landscape.

Competitive Landscape

The major global players in the automated dispensing machines market include Omnicell, Nordson Corporation, Baxter, bdtronic, Capsa Healthcare, TouchPoint Medical, McKesson Medical-Surgical Inc., Swisslog Healthcare, ARxIUM and ScriptPro LLC among others.

Why Purchase the Report?

• Pipeline & Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
• Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The Global Automated Dispensing Machines market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Type
• 3.2. Snippet by Size
• 3.3. Snippet by End-User
• 3.4. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Increasing incidence of medical errors
  • 4.1.2. Restraints
    • 4.1.2.1. High initial investments
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Force Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Patent Analysis
• 5.5. Regulatory Analysis
• 5.6. SWOT Analysis
• 5.7. Unmet Needs

6. By Type

• 6.1. Introduction
  • 6.1.1. Analysis and Y-o-Y Growth Analysis (%), By Type
  • 6.1.2. Market Attractiveness Index, By Type
• 6.2. Centralized*
  • 6.2.1. Introduction
  • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 6.3. Decentralized

7. By Size

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Size
  • 7.1.2. Market Attractiveness Index, By Size
• 7.2. Full Size Automated Dispensing Machines*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Countertop Automated Dispensing Machines

8. By End-User

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 8.1.2. Market Attractiveness Index, By End-User
• 8.2. Specialty Pharmacies*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Retail Pharmacy
• 8.4. Hospitals
• 8.5. Laboratories

9. By Region

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 9.1.2. Market Attractiveness Index, By Region
• 9.2. North America
  • 9.2.1. Introduction
  • 9.2.2. Key Region-Specific Dynamics
  • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Size
  • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.2.6.1. U.S.
    • 9.2.6.2. Canada
    • 9.2.6.3. Mexico
• 9.3. Europe
  • 9.3.1. Introduction
  • 9.3.2. Key Region-Specific Dynamics
  • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Size
  • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.3.6.1. Germany
    • 9.3.6.2. U.K.
    • 9.3.6.3. France
    • 9.3.6.4. Spain
    • 9.3.6.5. Italy
    • 9.3.6.6. Rest of Europe
• 9.4. South America
  • 9.4.1. Introduction
  • 9.4.2. Key Region-Specific Dynamics
  • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Size
  • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.4.6.1. Brazil
    • 9.4.6.2. Argentina
    • 9.4.6.3. Rest of South America
• 9.5. Asia-Pacific
  • 9.5.1. Introduction
  • 9.5.2. Key Region-Specific Dynamics
  • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Size
  • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.5.6.1. China
    • 9.5.6.2. India
    • 9.5.6.3. Japan
    • 9.5.6.4. South Korea
    • 9.5.6.5. Rest of Asia-Pacific
• 9.6. Middle East and Africa
  • 9.6.1. Introduction
  • 9.6.2. Key Region-Specific Dynamics
  • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Size
  • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. Competitive Landscape

• 10.1. Competitive Scenario
• 10.2. Market Positioning/Share Analysis
• 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

• 11.1. Omnicell*
  • 11.1.1. Company Overview
  • 11.1.2. Product Portfolio and Description
  • 11.1.3. Financial Overview
  • 11.1.4. Key Developments
• 11.2. Nordson Corporation
• 11.3. Baxter
• 11.4. bdtronic
• 11.5. Capsa Healthcare
• 11.6. TouchPoint Medical
• 11.7. McKesson Medical-Surgical Inc.
• 11.8. Swisslog Healthcare
• 11.9. ARxIUM
• 11.10. ScriptPro LLC

LIST NOT EXHAUSTIVE

12. Appendix

• 12.1. About Us and Services
• 12.2. Contact Us